ResearchMoz added Latest Research Report titled " Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017 " to it's Large Report database.
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.
Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the bone marrow. It then invades the blood. Symptoms usually develop slowly. Symptoms of CLL include abnormal bruising (if platelets are low), fever, infections that keep coming back (recur), loss of appetite or becoming full too quickly (early satiety) and weight loss. Treatment options include surgery, radiation therapy, chemotherapy or a combination of methods.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1135785
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chronic Lymphocytic Leukemia (CLL) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Lymphocytic Leukemia (CLL) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 7, 44, 51, 1, 3, 53, 12 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 4, 7, 10 and 7 molecules, respectively.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
Table of Contents 2
Introduction 7
Chronic Lymphocytic Leukemia (CLL) - Overview 8
Chronic Lymphocytic Leukemia (CLL) - Therapeutics Development 9
Chronic Lymphocytic Leukemia (CLL) - Therapeutics Assessment 35
Chronic Lymphocytic Leukemia (CLL) - Companies Involved in Therapeutics Development 51
Chronic Lymphocytic Leukemia (CLL) - Drug Profiles 102
Chronic Lymphocytic Leukemia (CLL) - Dormant Projects 748
Chronic Lymphocytic Leukemia (CLL) - Discontinued Products 756
Chronic Lymphocytic Leukemia (CLL) - Product Development Milestones 758
Appendix 770
List of Tables
Number of Products under Development for Chronic Lymphocytic Leukemia (CLL), H1 2017 29
Number of Products under Development by Companies, H1 2017 31
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 32
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 33
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017 34
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017 35
Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017 36
Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017 37
Number of Products under Development by Universities/Institutes, H1 2017 38
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.
Chronic lymphocytic leukemia (CLL) is a type of cancer that starts from white blood cells (called lymphocytes) in the bone marrow. It then invades the blood. Symptoms usually develop slowly. Symptoms of CLL include abnormal bruising (if platelets are low), fever, infections that keep coming back (recur), loss of appetite or becoming full too quickly (early satiety) and weight loss. Treatment options include surgery, radiation therapy, chemotherapy or a combination of methods.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1135785
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chronic Lymphocytic Leukemia (CLL) (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Chronic Lymphocytic Leukemia (CLL) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 7, 44, 51, 1, 3, 53, 12 and 1 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 4, 7, 10 and 7 molecules, respectively.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
Table of Contents 2
Introduction 7
Chronic Lymphocytic Leukemia (CLL) - Overview 8
Chronic Lymphocytic Leukemia (CLL) - Therapeutics Development 9
Chronic Lymphocytic Leukemia (CLL) - Therapeutics Assessment 35
Chronic Lymphocytic Leukemia (CLL) - Companies Involved in Therapeutics Development 51
Chronic Lymphocytic Leukemia (CLL) - Drug Profiles 102
Chronic Lymphocytic Leukemia (CLL) - Dormant Projects 748
Chronic Lymphocytic Leukemia (CLL) - Discontinued Products 756
Chronic Lymphocytic Leukemia (CLL) - Product Development Milestones 758
Appendix 770
List of Tables
Number of Products under Development for Chronic Lymphocytic Leukemia (CLL), H1 2017 29
Number of Products under Development by Companies, H1 2017 31
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 32
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 33
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017 34
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017 35
Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017 36
Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017 37
Number of Products under Development by Universities/Institutes, H1 2017 38
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
No comments:
Post a Comment